Humonix Biosciences Inc

Biotech · Private

3D human eye tissue model system using microfluidic technology for drug screening

Grants
$1.6M
2 awards
Sector median: 1
Raised
—
No Form D on record
Contracts
—
No federal contracts on record
Patents
—
No published records under this name
Sector median: 2

Capital Timeline

Federal above the line · equity below · node area scaled to amount
Capital and federal award history
DateEventSourceAmount
Federal grantNational Science Foundation · Phase I · STTR Phase I: Development High-throughput Screening System for Glaucoma Therapeutics Using a Bioengineered Human Eye Tissue$225,000
Federal grantNational Science Foundation · Phase II · SBIR Phase II: Development of a High-Throughput Drug Screening System for Eye Diseases$1,409,979
Federal grant · SBIR/STTR

Peer position

Biotech · 4373 companies · ranked on federal contract value
Biotech companies ranked by federal contract value
#CompanyContractsDisclosed equity
2306BICYCLE THERAPEUTICS PLC—$555M
2307Gatehouse Bio, Inc.—$5.4M
2308Synlico Inc.—$5.2M
2309Humonix Biosciences Inc——
2310Deep Origin Inc.—$29M
2311Vivace Therapeutics—$61M
2312Volta Labs, Inc.—$29M

Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.

Regulatory activity · Biotech

Sector-level, not company-level

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.